111 related articles for article (PubMed ID: 15686900)
1. Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonists.
Grey J; Dyck B; Rowbottom MW; Tamiya J; Vickers TD; Zhang M; Zhao L; Heise CE; Schwarz D; Saunders J; Goodfellow VS
Bioorg Med Chem Lett; 2005 Feb; 15(4):999-1004. PubMed ID: 15686900
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1.
Rowbottom MW; Vickers TD; Dyck B; Grey J; Tamiya J; Zhang M; Kiankarimi M; Wu D; Dwight W; Wade WS; Schwarz D; Heise CE; Madan A; Fisher A; Petroski R; Goodfellow VS
Bioorg Med Chem Lett; 2006 Sep; 16(17):4450-7. PubMed ID: 16814542
[TBL] [Abstract][Full Text] [Related]
3. Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists.
Zhang M; Tamiya J; Nguyen L; Rowbottom MW; Dyck B; Vickers TD; Grey J; Schwarz DA; Heise CE; Haelewyn J; Mistry MS; Goodfellow VS
Bioorg Med Chem Lett; 2007 May; 17(9):2535-9. PubMed ID: 17329101
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2.
Hudson S; Kiankarimi M; Rowbottom MW; Vickers TD; Wu D; Pontillo J; Ching B; Dwight W; Goodfellow VS; Schwarz D; Heise CE; Madan A; Wen J; Ban W; Wang H; Wade WS
Bioorg Med Chem Lett; 2006 Sep; 16(18):4922-30. PubMed ID: 16824755
[TBL] [Abstract][Full Text] [Related]
5. Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.
Kim N; Meyers KM; Mendez-Andino JL; Warshakoon NC; Ji W; Wos JA; Colson A; Mitchell MC; Davis JR; Pinney BB; Reizes O; Hu XE
Bioorg Med Chem Lett; 2006 Oct; 16(20):5445-50. PubMed ID: 16879961
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.
Wu WL; Burnett DA; Caplen MA; Domalski MS; Bennett C; Greenlee WJ; Hawes BE; O'Neill K; Weig B; Weston D; Spar B; Kowalski T
Bioorg Med Chem Lett; 2006 Jul; 16(14):3674-8. PubMed ID: 16690315
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
Rowbottom MW; Vickers TD; Tamiya J; Zhang M; Dyck B; Grey J; Schwarz D; Heise CE; Hedrick M; Wen J; Tang H; Wang H; Fisher A; Aparicio A; Saunders J; Goodfellow VS
Bioorg Med Chem Lett; 2007 Apr; 17(8):2171-8. PubMed ID: 17350839
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of biarylcarboxamide bis-aminopyrrolidine urea derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
Rowbottom MW; Vickers TD; Dyck B; Tamiya J; Zhang M; Zhao L; Grey J; Provencal D; Schwarz D; Heise CE; Mistry M; Fisher A; Dong T; Hu T; Saunders J; Goodfellow VS
Bioorg Med Chem Lett; 2005 Jul; 15(14):3439-45. PubMed ID: 15950467
[TBL] [Abstract][Full Text] [Related]
9. Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development.
Rami HK; Thompson M; Stemp G; Fell S; Jerman JC; Stevens AJ; Smart D; Sargent B; Sanderson D; Randall AD; Gunthorpe MJ; Davis JB
Bioorg Med Chem Lett; 2006 Jun; 16(12):3287-91. PubMed ID: 16580202
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1.
Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Semple G; Tran TA; Kramer B; Hsu D; Casper M; Thomsen B; Beeley N; Sekiguchi Y
Bioorg Med Chem Lett; 2005 May; 15(10):2565-9. PubMed ID: 15863317
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists.
Wu WL; Burnett DA; Spring R; Qiang L; Sasikumar TK; Domalski MS; Greenlee WJ; O'Neill K; Hawes BE
Bioorg Med Chem Lett; 2006 Jul; 16(14):3668-73. PubMed ID: 16690312
[TBL] [Abstract][Full Text] [Related]
13. 4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists.
Receveur JM; Bjurling E; Ulven T; Little PB; Nørregaard PK; Högberg T
Bioorg Med Chem Lett; 2004 Oct; 14(20):5075-80. PubMed ID: 15380202
[TBL] [Abstract][Full Text] [Related]
14. Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists.
Cole AG; Stroke IL; Brescia MR; Simhadri S; Zhang JJ; Hussain Z; Snider M; Haskell C; Ribeiro S; Appell KC; Henderson I; Webb ML
Bioorg Med Chem Lett; 2006 Jan; 16(1):200-3. PubMed ID: 16213722
[TBL] [Abstract][Full Text] [Related]
15. Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series.
Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Tsutsumi T; Sudo M; Endo N; Muroga Y; Hada T; Fanning D; Saunders J; Kato Y; Myers PL; Tarby CM
Bioorg Med Chem Lett; 2008 Mar; 18(6):1869-73. PubMed ID: 18313297
[TBL] [Abstract][Full Text] [Related]
16. Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.
Galiano S; Ceras J; Cirauqui N; Pérez S; Juanenea L; Rivera G; Aldana I; Monge A
Bioorg Med Chem; 2007 Jun; 15(11):3896-911. PubMed ID: 17407817
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J
Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists.
Arienzo R; Clark DE; Cramp S; Daly S; Dyke HJ; Lockey P; Norman D; Roach AG; Stuttle K; Tomlinson M; Wong M; Wren SP
Bioorg Med Chem Lett; 2004 Aug; 14(15):4099-102. PubMed ID: 15225734
[TBL] [Abstract][Full Text] [Related]
19. Heteroaryl beta-tetralin ureas as novel antagonists of human TRPV1.
Jetter MC; Youngman MA; McNally JJ; McDonnell ME; Zhang SP; Dubin AE; Nasser N; Codd EE; Flores CM; Dax SL
Bioorg Med Chem Lett; 2007 Nov; 17(22):6160-3. PubMed ID: 17892935
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrocarboline analogs as MCH-1 antagonists.
Henderson AJ; Deering D; Grabowski JF; Hadden M; Jiang X; Khmelnitsky Y; Luche M; Surman MD; Cheetham S; Vickers S; Viggers J; Guzzo PR
Bioorg Med Chem Lett; 2010 Dec; 20(23):7024-8. PubMed ID: 20952195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
